
Hims Launches Compounded GLP-1 Pill, CVS Forces Biosimilars – This Week in Biotech #88
6.2.2026
0:00
6:05
Compounded semaglutide draws FDA scrutiny as Novo Nordisk guides 2026 lower and Eli Lilly leans into a $50 Medicare copay (Jan 30-Feb 5, 2026).
Follow Biotech Blueprint at biotechblueprint.com.
Flere episoder fra "Biotech Blueprint"



Gå ikke glip af nogen episoder af “Biotech Blueprint” - abonnér på podcasten med gratisapp GetPodcast.








